SILK
SILK Real Time Price USDRecent trades of SILK by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Daniel S. Goldman House / D | Sale $1,001 - $15,000 | Mar 06, 2023 |
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SILK's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
SILK Revenue by Segment or Geography
New patents grants
-
Patent Title: Suture delivery device Mar. 11, 2025
-
Patent Title: Systems and methods for transcatheter aortic valve treatment Feb. 11, 2025
-
Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Jan. 14, 2025
-
Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Jan. 14, 2025
-
Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Dec. 03, 2024
-
Patent Title: Systems and methods for treating a carotid artery Dec. 03, 2024
-
Patent Title: Methods and systems for treatment of acute ischemic stroke Nov. 19, 2024
-
Patent Title: Systems and methods for treating a carotid artery Oct. 29, 2024
-
Patent Title: Methods and devices for transcarotid access Aug. 06, 2024
-
Patent Title: Endoluminal delivery of anesthesia Aug. 06, 2024
-
Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Jul. 23, 2024
-
Patent Title: Vessel access and closure assist system and method Jul. 09, 2024
-
Patent Title: Method and apparatus for treating an arterial lesion Mar. 05, 2024
-
Patent Title: Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization Jan. 09, 2024
-
Patent Title: Systems and methods for aspirating from a body lumen Jan. 02, 2024
-
Patent Title: Method and apparatus for treating an arterial lesion Dec. 26, 2023
-
Patent Title: Suture delivery device Dec. 12, 2023
-
Patent Title: Methods and devices for transcarotid access Sep. 19, 2023
-
Patent Title: Methods and systems for treatment of acute ischemic stroke May. 23, 2023
-
Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Sep. 06, 2022
-
Patent Title: Suture delivery device Jul. 19, 2022
-
Patent Title: Interventional catheter system and methods Jun. 21, 2022
-
Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Jun. 21, 2022
-
Patent Title: Transcarotid neurovascular catheter Apr. 05, 2022
-
Patent Title: Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization Oct. 12, 2021
-
Patent Title: Methods and systems for treatment of acute ischemic stroke Aug. 31, 2021
-
Patent Title: Devices and methods for endoluminal delivery of either fluid or energy for denervation Aug. 24, 2021
-
Patent Title: Methods and devices for transcarotid access Jun. 08, 2021
-
Patent Title: Vessel access and closure assist system and method Apr. 13, 2021
-
Patent Title: Systems and methods for treating a carotid artery Mar. 23, 2021
-
Patent Title: Systems and methods for aspirating from a body lumen Mar. 09, 2021
-
Patent Title: Systems and methods for transcatheter aortic valve treatment Feb. 23, 2021
-
Patent Title: Vascular implant Feb. 16, 2021
-
Patent Title: Suture delivery device Jan. 05, 2021
-
Patent Title: Methods and devices for transcarotid access Dec. 15, 2020
-
Patent Title: Endoluminal delivery of anesthesia Nov. 10, 2020
-
Patent Title: Method and apparatus for treating a carotid artery Sep. 22, 2020
-
Patent Title: Method and apparatus for treating an arterial lesion Jul. 28, 2020
-
Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Jul. 14, 2020
-
Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Jan. 28, 2020
-
Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Nov. 26, 2019
-
Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Oct. 01, 2019
-
Patent Title: Systems and methods for aspirating from a body lumen Aug. 27, 2019
-
Patent Title: Transcarotid neurovascular catheter Aug. 20, 2019
-
Patent Title: Systems and methods for treating a carotid artery Aug. 06, 2019
-
Patent Title: Suture delivery device Jul. 23, 2019
-
Patent Title: Endoluminal delivery of anesthesia Jun. 25, 2019
-
Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow May. 14, 2019
-
Patent Title: Devices and methods for endoluminal delivery of either fluid or energy for denervation Apr. 30, 2019
-
Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Mar. 26, 2019
Federal grants, loans, and purchases
- $137,160 2025-01-08 00:00:00 Agency: Department of Veterans Affairs
- $10,507 2024-06-27 00:00:00 Agency: Department of Veterans Affairs
- $16,014 2024-04-12 00:00:00 Agency: Department of Veterans Affairs
- $37,366 2023-11-02 00:00:00 Agency: Department of Veterans Affairs
- $42,447 2023-06-26 00:00:00 Agency: Department of Veterans Affairs
- $68,233 2023-04-20 00:00:00 Agency: Department of Veterans Affairs
- $65,175 2022-06-09 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $10,200 2021-10-14 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded from public contracts
Recent insights relating to SILK
Recent picks made for SILK stock on CNBC
ETFs with the largest estimated holdings in SILK
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $SILK stock a Buy, Sell, or Hold?
- What is the price target for $SILK stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $SILK stock?
- Who owns the most shares of $SILK stock?
- What funds own $SILK stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SILK Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.